Nuo Therapeutics Files Q1 2025 10-Q
Ticker: AURX · Form: 10-Q · Filed: Apr 30, 2025 · CIK: 1091596
| Field | Detail |
|---|---|
| Company | Nuo Therapeutics, Inc. (AURX) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, medical-instruments
TL;DR
Nuo Therapeutics Q1 2025 10-Q filed. Check financials.
AI Summary
Nuo Therapeutics, Inc. filed a 10-Q for the period ending March 31, 2025. The company, formerly known as CytomediX Inc. and Autologous Wound Therapy Inc., is incorporated in Delaware and operates in the surgical and medical instruments sector. Their business address is in Houston, Texas.
Why It Matters
This filing provides an update on Nuo Therapeutics' financial performance and operational status for the first quarter of 2025, which is crucial for investors to assess the company's trajectory.
Risk Assessment
Risk Level: low — This is a routine quarterly filing with no immediate red flags or significant new information presented in the provided snippet.
Key Players & Entities
- Nuo Therapeutics, Inc. (company) — Filer
- CytomediX Inc. (company) — Former company name
- Autologous Wound Therapy Inc. (company) — Former company name
- 20250331 (date) — Period of report
- 20250430 (date) — Filing date
- 832-236-9060 (phone_number) — Business phone
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the first quarter of 2025.
What is Nuo Therapeutics, Inc.'s Standard Industrial Classification code?
Nuo Therapeutics, Inc. is classified under SIC code 3841, which is for Surgical & Medical Instruments & Apparatus.
When was Nuo Therapeutics, Inc. previously known by other names?
The company was formerly known as CytomediX Inc. (name change date 20000511) and Autologous Wound Therapy Inc. (name change date 20000407).
Where is Nuo Therapeutics, Inc. located?
The company's business and mailing address is 8285 El Rio, Suite 150, Houston, TX 77054.
What is the SEC file number for Nuo Therapeutics, Inc.?
The SEC file number for Nuo Therapeutics, Inc. is 001-32518.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2025 regarding Nuo Therapeutics, Inc. (AURX).